These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7818557)

  • 1. Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone.
    Kahaleh B; Matucci-Cerinic M
    Arthritis Rheum; 1995 Jan; 38(1):1-4. PubMed ID: 7818557
    [No Abstract]   [Full Text] [Related]  

  • 2. Raynaud's phenomenon.
    Wigley FM; Flavahan NA
    Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon.
    Seibold JR; Harris JN
    J Rheumatol; 1985 Feb; 12(1):99-103. PubMed ID: 2580093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal regulators and vascular dysfunction in Raynaud's phenomenon and systemic sclerosis.
    Fonseca C; Abraham D; Ponticos M
    Curr Vasc Pharmacol; 2009 Jan; 7(1):34-9. PubMed ID: 19149638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raynaud phenomenon and scleroderma].
    Haustein UF
    Hautarzt; 1996 May; 47(5):336-40. PubMed ID: 8707577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon.
    Flavahan NA
    Rheum Dis Clin North Am; 2008 Feb; 34(1):81-7; vii. PubMed ID: 18329534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iontophoretic evaluation of vascular reactivity to acetylcholine in patients with primary Raynaud's phenomenon and systemic sclerosis.
    Marasini B; Conciato L
    Clin Rheumatol; 2001; 20(6):451-2. PubMed ID: 11771535
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma.
    Freedman RR; Girgis R; Mayes MD
    J Rheumatol; 2001 Jan; 28(1):119-21. PubMed ID: 11196511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma.
    Freedman RR; Girgis R; Mayes MD
    J Rheumatol; 1999 Nov; 26(11):2386-8. PubMed ID: 10555897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-arginine therapy in Raynaud's phenomenon?
    Agostoni A; Marasini B; Biondi ML; Bassani C; Cazzaniga A; Bottasso B; Cugno M
    Int J Clin Lab Res; 1991; 21(2):202-3. PubMed ID: 1815764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma.
    Freedman RR; Girgis R; Mayes MD
    Lancet; 1999 Aug; 354(9180):739. PubMed ID: 10475187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cold and emotional stress in Raynaud's disease and scleroderma.
    Freedman RR; Ianni P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and Raynaud's phenomenon.
    Seibold JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S95-8. PubMed ID: 2412070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Esophageal motility, systemic scleroderma and Raynaud's phenomenon].
    Gosselin A
    Gastroenterol Clin Biol; 1985 Feb; 9(2):127-9. PubMed ID: 3979733
    [No Abstract]   [Full Text] [Related]  

  • 15. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Raynaud's disease.
    Cooke JP; Marshall JM
    Vasc Med; 2005 Nov; 10(4):293-307. PubMed ID: 16444858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raynaud's phenomenon and systemic sclerosis.
    Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
    Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of vasospastic attacks despite digital nerve block in Raynaud's disease and phenomenon.
    Freedman RR; Mayes MD; Sabharwal SC
    Circulation; 1989 Oct; 80(4):859-62. PubMed ID: 2791249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon and vascular disease in scleroderma.
    Kahaleh MB
    Curr Opin Rheumatol; 1994 Nov; 6(6):621-7. PubMed ID: 7865384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.